G Laurent Selected Research

G Laurent Research Topics

Disease

10	Neoplasms (Cancer) 12/2019 - 11/2000
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2006 - 08/2001
3	Necrosis 03/2001 - 03/2000
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2013 - 08/2013
2	Neoplasm Metastasis (Metastasis) 11/2011 - 11/2004
2	Carcinogenesis 06/2011 - 05/2001
2	Ischemia 06/2011 - 01/2005
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2010 - 07/2010
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2006 - 08/2004
2	Breast Neoplasms (Breast Cancer) 11/2004 - 11/2000
2	Body Weight (Weight, Body) 01/2003 - 03/2000
2	Malnutrition (Nutritional Deficiencies) 01/2003 - 01/2001
1	Hyperpigmentation 08/2020
1	Lymphoma (Lymphomas) 12/2019
1	Heart Failure 11/2019
1	Hemorrhage 11/2019
1	Hodgkin Disease (Hodgkin's Disease) 01/2019
1	Gliosarcoma 06/2016
1	Nephrogenic Fibrosing Dermopathy 06/2016
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2013
1	Melanoma (Melanoma, Malignant) 11/2011
1	Lymphatic Metastasis 11/2011
1	Starvation 06/2011
1	Carcinoma (Carcinomatosis) 03/2010
1	Urinary Bladder Neoplasms (Bladder Cancer) 03/2010
1	Pericarditis 02/2007
1	Heart Diseases (Heart Disease) 01/2005
1	Neuroblastoma 08/2004
1	Chromosome Aberrations (Chromosome Abnormalities) 08/2004
1	Leukemia 09/2002
1	Infections 07/2002
1	Diabetes Mellitus 07/2002
1	Bacteremia 07/2002
1	Atherosclerosis 07/2002
1	Accessory Atrioventricular Bundle 01/2002

Drug/Important Bio-Agent (IBA)

4	AntibodiesIBA 08/2013 - 01/2000
3	Rituximab (Mabthera)FDA Link 12/2013 - 07/2010
3	Proteins (Proteins, Gene)FDA Link 12/2013 - 01/2003
3	Daunorubicin (Cerubidine)FDA LinkGeneric 08/2001 - 01/2000
2	DNA (Deoxyribonucleic Acid)IBA 11/2011 - 03/2000
2	CeramidesIBA 08/2004 - 01/2000
2	NitrogenIBA 01/2003 - 03/2000
2	CreatinineIBA 01/2003 - 03/2000
2	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 10/2001 - 02/2001
2	AnthracyclinesIBA 08/2001 - 03/2001
2	Diethylstilbestrol (Stilbestrol)FDA Link 05/2001 - 11/2000
2	Estrogens (Estrogen)FDA Link 05/2001 - 11/2000
2	Pharmaceutical PreparationsIBA 03/2001 - 03/2000
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2000 - 01/2000
1	Niacinamide (Nicotinamide)FDA LinkGeneric 08/2020
1	AnticoagulantsIBA 11/2019
1	Chelating AgentsIBA 06/2016
1	GoldIBA 06/2016
1	IonsIBA 06/2016
1	GadoliniumIBA 06/2016
1	enzastaurinIBA 12/2013
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 12/2013
1	obinutuzumabIBA 08/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	Messenger RNA (mRNA)IBA 11/2011
1	Monophenol Monooxygenase (Tyrosinase)IBA 11/2011
1	EnzymesIBA 06/2011
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2011
1	IntegrinsIBA 06/2011
1	fludarabineIBA 07/2010
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2010
1	beta CateninIBA 07/2006
1	ElectrolytesIBA 01/2005
1	Diphosphonates (Bisphosphonates)IBA 11/2004
1	Clodronic Acid (Clodronate)IBA 11/2004
1	Tamoxifen FDA LinkGeneric 11/2004
1	SteroidsIBA 11/2004
1	Aromatase InhibitorsIBA 11/2004
1	Phosphotransferases (Kinase)IBA 08/2004
1	Nerve Growth Factor (NGF)IBA 08/2004
1	Phospholipases (Phospholipase)IBA 08/2004
1	bcr-abl Fusion ProteinsIBA 08/2004
1	Imatinib Mesylate (Gleevec)FDA Link 08/2004
1	Serum AlbuminIBA 01/2003
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2003
1	Mitoxantrone (Novantrone)FDA LinkGeneric 09/2002
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 07/2002
1	IronIBA 07/2002
1	SiliconesIBA 07/2002
1	antineoplaston A10 (A 10)IBA 01/2002
1	fas Receptor (CD95 Antigen)IBA 12/2001
1	Indicators and Reagents (Reagents)IBA 12/2001

Therapy/Procedure

8	Therapeutics 12/2019 - 09/2002
3	Drug Therapy (Chemotherapy) 12/2019 - 03/2010
1	Cryosurgery 11/2019
1	Contraindications 11/2019
1	Intravenous Injections 06/2016
1	Ligation 06/2011
1	Immunotherapy 07/2010
1	Radiotherapy 03/2010
1	Conservative Treatment 03/2010
1	Pericardiectomy 02/2007
1	Catheters 07/2002
1	Renal Dialysis (Hemodialysis) 07/2002
1	Radiofrequency Ablation 01/2002